Kistler-Tiffany Companies’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kistler-Tiffany Companies’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$6.21K	Hold	182	–	–	﹤0.01%	747
2023 Q1	$5.47K	Hold	182	–	–	﹤0.01%	682
2022 Q4	$5.14K	Sell	182 -950	-84%	-$30.2K	﹤0.01%	686
2022 Q3	$37K	Sell	1,132 -380	-25%	-$14K	0.01%	414
2022 Q2	$48K	Hold	1,512	–	–	0.01%	381
2022 Q1	$69K	Sell	1,512 -20	-1%	-$954	0.01%	353
2021 Q4	$94K	Buy	1,532 +313	+26%	+$21.6K	0.02%	297
2021 Q3	$91K	Hold	1,219	–	–	0.02%	286
2021 Q2	$113K	Buy	1,219 +354	+41%	+$30.1K	0.03%	256
2021 Q1	$77K	Hold	865	–	–	0.02%	276
2020 Q4	$81K	Hold	865	–	–	0.02%	248
2020 Q3	$55K	Buy	+865	New	+$50.7K	0.02%	260

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Kistler-Tiffany Companies's ARKG Position: Q2 2023 in Review

Kistler-Tiffany Companies held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2023 at 182 shares worth $6.21K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Kistler-Tiffany Companies first reported a position in ARKG in Q3 2020 and has held it in 12 quarters since. The position peaked at $113K in Q2 2021. 291 funds tracked by Wall St. Rank hold ARKG as of Q2 2023.

Kistler-Tiffany Companies held 182 shares of ARK Genomic Revolution ETF worth $6.21K as of Q2 2023.
Kistler-Tiffany Companies left its ARK Genomic Revolution ETF share count unchanged in Q2 2023.
ARK Genomic Revolution ETF made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #747 holding.
Kistler-Tiffany Companies first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 12 quarters since.
Kistler-Tiffany Companies's ARK Genomic Revolution ETF position peaked at $113K in Q2 2021.
291 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.